Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Call for papersOncology

Call for Papers: Clinical trials for treatment and management of pancreatic cancers (BMC Medicine)

BMC Medicine’s collection “Clinical trials for treatment and management of pancreatic cancers” focuses on trials of new treatments and management strategies for pancreatic cancer. This guide outlines topic areas consistent with that scope, fit checks and the types of contribution likely to be valued.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Deadline
25 June 2027
Last checked
10 November 2026
Reading time
5 min
Sources
1
Submit through the official call

Key dates

Manuscript deadline
25 June 2027
Details last checked
10 November 2026
Open the official call

About the journal

Journal
BMC Medicine
Publisher
BMC, part of Springer Nature
Call type
Call for papers
Scope
Trials of new treatments and management strategies for pancreatic cancer.
Guest editors
Listed on the official collection page
Access and fees
Open access; an article processing charge normally applies on acceptance
Originality
Original work, not under review elsewhere; confirm on the official page

Topics consistent with the call

  • Randomised trials of systemic therapies for advanced pancreatic cancer
  • Trials of neoadjuvant and adjuvant strategies in resectable or borderline disease
  • Studies of radiotherapy, surgery and multimodal management of pancreatic cancer
  • Trials of supportive care, symptom control and nutrition in pancreatic cancer
  • Biomarker-driven and precision oncology trials in pancreatic adenocarcinoma
  • Trial methodology, recruitment and outcome measures in pancreatic cancer research

Based on the published scope; the full list of themes is on the official call page.

Is your work a fit? Check before you write

  1. The manuscript reports or analyses a clinical trial, or closely related trial work, in pancreatic cancer treatment or management.
  2. The trial was prospectively registered and the report follows CONSORT or the relevant extension.
  3. The findings are relevant to clinical decision-making or future trial design for a broad medical readership.
  4. Secondary analyses, protocols or reviews state clearly how they relate to trial evidence, and their eligibility is confirmed on the official call page.
  5. The manuscript is complete, approved by all co-authors and submitted before 25 June 2027.

Why This Call Is a Priority Now

Pancreatic cancer is often diagnosed at an advanced stage and remains one of the most difficult cancers to treat, so well-conducted trials are essential to establish which treatments and management strategies help patients. Questions about the sequencing of chemotherapy, surgery and radiotherapy, the role of biomarkers and the value of supportive care continue to need robust evidence. A themed collection in a general medical journal gives trial results, including negative or neutral findings, a visible home and helps clinicians see the evidence base as a whole.

Who Should Submit

Academic backgrounds

  • Medical and clinical oncology
  • Hepatopancreatobiliary surgery
  • Radiation oncology
  • Palliative and supportive care
  • Clinical trial methodology and biostatistics

Institutions and sectors

  • Comprehensive cancer centres and university hospitals
  • Cooperative oncology trial groups
  • Pharmaceutical and biotechnology companies
  • Clinical trials units

Article types commonly published in BMC Medicine

  • Clinical trials and other interventional studies
  • Observational studies
  • Systematic reviews and meta-analyses
  • Translational and mechanistic research

What the Editors Typically Value

  1. Well-powered randomised trials that answer a clinically important treatment question.
  2. Transparent reporting of negative or neutral trial results that prevent unnecessary duplication.
  3. Trials that address quality of life, symptom burden or supportive care alongside survival.
  4. Innovations in trial design, such as biomarker-stratified or adaptive approaches, with lessons for future studies.

Paper Ideas You Could Develop

Neoadjuvant therapy trialA randomised trial report comparing neoadjuvant chemotherapy regimens in borderline resectable pancreatic cancer, with resection rate and survival outcomes.
Nutritional support interventionA trial evaluating structured nutritional support or enzyme replacement during chemotherapy and its effect on treatment tolerance and quality of life.
Recruitment and retention reviewA systematic review of recruitment, attrition and outcome reporting in pancreatic cancer trials, with recommendations for future trial design.

Your Plan to the Deadline

A suggested schedule working back from 25 June 2027. Adjust it to the stage your work has reached.

  1. By 11 May 2027

    Open the official collection page and the BMC Medicine submission guidelines; confirm the scope, article types and guest editors.

  2. By 25 May 2027

    Write a one-paragraph statement of your research question, design and the contribution your paper makes to the collection.

  3. By 4 Jun 2027

    Complete the analysis and agree the key findings, figures and tables with your co-authors.

  4. By 15 Jun 2027

    Draft the full manuscript to the BMC Medicine article type and the relevant reporting guideline.

  5. By 20 Jun 2027

    Circulate the draft to co-authors and an independent reader; revise for clarity, accuracy and completeness.

  6. By 23 Jun 2027

    Complete final checks: formatting, references, declarations, data availability statement and cover letter.

  7. By 25 Jun 2027

    Submit through the journal’s online system, selecting the collection, after re-checking the official call page.

What you gain from publishing here

  • Publication in BMC Medicine, reaching readers working on this topic.
  • A themed collection that groups your paper with related work.
  • Editorial and peer feedback that can strengthen the work, whatever the decision.
  • A peer-reviewed output for your CV, thesis or grant reporting.

What happens after you submit

  1. Submission: upload through the BMC Medicine online system and select the collection.
  2. Editorial screening: the editors check fit with the collection; papers outside its scope may be returned without review.
  3. Peer review: suitable papers are sent to reviewers under the journal’s review model.
  4. Revision and decision: respond to each reviewer comment and keep a record of the changes.
  5. Production: accepted papers move to proofs and open access publication, with the article processing charge set out by the publisher.

What the Collection Is Looking For

The collection is looking for clinical trial evidence on new treatments and management strategies for pancreatic cancer. Consistent with BMC Medicine’s remit, it is likely to favour rigorously conducted, registered trials reported transparently, alongside closely related work such as secondary analyses or reviews of trial evidence where eligible. Studies that address survival, quality of life and the practical management of the disease, including those with neutral results, fit the stated scope.

Read the call itselfThis guide summarises the call. Open the official collection page before you plan a submission, and record the date you checked it and the guest editors listed.Open the official call

Expert help

How Pubrica Can Help With This Submission

Pubrica’s subject specialists can review, write, edit, format and prepare your manuscript for this call, planned back from the deadline. You remain the author of your work.

Original research article writingManuscript writing from your data, structured to the journal’s article type and reporting guideline. Biostatistics and statistical programmingStatistical analysis plans, analysis, simulation code and statistical review of results. Systematic reviewProtocol, screening, data extraction and risk-of-bias assessment for review articles. Journal formattingFormatting of the manuscript, references, figures and tables to the journal’s guidelines. Cover letterA cover letter that explains how the manuscript fits the collection and the journal’s scope. Journal submissionPreparation of submission files and completion of the journal’s online submission system.
Go to the official call

FAQs

Questions Authors Ask

The published deadline is 25 June 2027. Collections can close early or be extended, so confirm the date on the official call page before you plan your submission.

The guest editors are listed on the official collection page. Check their research interests, as they help to judge whether your manuscript fits the collection.

The stated scope centres on trials, so a retrospective cohort may be less suited unless it directly informs trial design or interprets trial evidence. Authors should confirm on the official call page whether observational studies are accepted for this collection.

BMC journals publish articles open access, and an article processing charge normally applies on acceptance. Check the journal’s fees and funding page, and whether your institution has an agreement that covers the charge, before you submit.

Sources

  1. BMC Medicine. (2026). Clinical trials for treatment and management of pancreatic cancers [Collection call for papers]. BMC, part of Springer Nature. Retrieved 10 November 2026, from https://link.springer.com/collections/edgaibciij

How to cite this page

Pubrica Insights. (2026). Call for Papers: Clinical trials for treatment and management of pancreatic cancers (BMC Medicine). Pubrica. https://pubrica.com/insights/calls-and-conferences/clinical-trials-for-treatment-and-management-of-pancreatic-cancers/

  • Pancreatic cancer
  • Clinical trials
  • Oncology
  • Chemotherapy
  • Supportive care

Other Open Calls

Closes 17 November 2026Organoids: connecting molecular insights and clinical practiceBMC Medicine Closes 30 November 2026New research in autismBMC Medicine Closes 7 December 2026Antibody-drug conjugates for cancer treatment: translational and clinical perspectivesBMC Medicine

All calls and conferencesPre-submission peer reviewAll Insights

Clinical trials for treatment and management of pancreatic cancers (BMC Medicine)Deadline 25 June 2027

Official call
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.